本文へスキップ

相互作用

Avapritinib + Imatinib

重症度: 重大

Avapritinib and Imatinib: major interaction.

最終更新日

医療従事者向け・参照専用。このページは簡潔な要約であり、医学的助言ではなく、公式の添付文書や臨床判断に代わるものではありません。処方・調剤の前に必ず確認してください。

このページの臨床コンテンツは英語でのみ提供されています。

概要

Avapritinib is a CYP3A4 substrate, and imatinib is a moderate CYP3A4 inhibitor. Avapritinib exposure may increase, raising risks of cognitive effects, intracranial hemorrhage and edema. Both are kinase inhibitors, and imatinib is also used in GIST, where combination is not typical.

この相互作用をわかりやすく説明すると

Avapritinib and Imatinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Avapritinib belongs to Oncology; Imatinib belongs to Oncology.

エビデンスレベル: Moderate

なぜ起こるのか

CYP3A4 inhibition by imatinib reduces avapritinib clearance.

対処法

Avoid the combination if possible. If necessary, use the reduced avapritinib starting dose from labeling and monitor for cognitive effects and bleeding.

薬剤師に尋ねること

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+会員向け

ページ全体を見る

アカウントを作成してPro+トライアルを始めると、AvapritinibとImatinibの臨床対応の詳細なアドバイス、追加の注記、エビデンスの詳細、処方全体を対象とした相互作用チェッカーを利用できます。

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

WebでPro+を14日間無料でお試し。カード登録不要。

よくある質問

Can I take Avapritinib with Imatinib?

MediHelp rates the interaction as major. Avapritinib and Imatinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Avapritinib is a CYP3A4 substrate, and imatinib is a moderate CYP3A4 inhibitor. Avapritinib exposure may increase, raising risks of cognitive effects, intracranial hemorrhage and edema. Both are kinase inhibitors, and imatinib is also used in GIST, where combination is not typical.

How serious is the interaction between Avapritinib and Imatinib?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination if possible. If necessary, use the reduced avapritinib starting dose from labeling and monitor for cognitive effects and bleeding.

What other medicines interact with Imatinib?

MediHelp also lists interactions of Imatinib with, for example, Lomitapide, Lonafarnib, Amobarbital. The full list is on the Imatinib page.

完全なモノグラフ、用量、相互作用チェッカーはMediHelpアプリで

MediHelpアプリで、完全なリファレンスを開き、複数薬剤の相互作用をチェックし、用量ツールを利用できます。

A–Zで探す · 相互作用

アプリを入手 ログイン